Stockpolly
Search
ARIA · NYSE · Biotechnology

ARIA Opportunities ETF (ARIA)

$24.54
At close0.00 (0.00%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

192.71M company shares as of Sep 3, 2026 · holders as of their latest filing

The share count is from the company's Jul 2016 quarterly report; nothing newer is on file here.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
George Bickerstaff1Insiderdirector
0.00%0Form 4filed Feb 16, 2017 ↗
Daniel M. Bollag1Insiderofficer: Sr. VP, Reg. Affairs & Quality
0.00%0Form 4filed Feb 16, 2017 ↗
Timothy P. Clackson1Insiderofficer: President, R&D, CSO
0.00%0Form 4filed Feb 16, 2017 ↗
Hugh M. Cole1Insiderofficer: SVP, Chief Business Officer
0.00%0Form 4filed Feb 16, 2017 ↗
Alexander J. Denner1Insiderdirector
0.00%0Form 4filed Feb 16, 2017 ↗
Jules Haimovitz1Insiderdirector
0.00%0Form 4filed Feb 16, 2017 ↗
Jennifer Lyn Herron1Insiderofficer: Exec V.P. Chief Comm'l Officer
0.00%0Form 4filed Feb 16, 2017 ↗
Paris Panayiotopoulos1Insiderdirector, officer: President and CEO
0.00%0Form 4filed Feb 16, 2017 ↗
Anna Protopapas1Insiderdirector
0.00%0Form 4filed Feb 16, 2017 ↗
Norbert G. Riedel1Insiderdirector
0.00%0Form 4filed Feb 16, 2017 ↗
Sarah J. Schlesinger1Insiderdirector
0.00%0Form 4filed Feb 16, 2017 ↗
Manmeet Singh Soni1Insiderofficer: EVP, CFO & Treasurer
0.00%0Form 4filed Feb 16, 2017 ↗
  1. Last filed Feb 16, 2017; leaving the company requires no filing. Not in the bar.

Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

No 13D/G filer at 5% or more on record.

Insider tradesForm 4

Latest trades

Nothing filed in the last 12 months.

CongressHouse and Senate disclosures

Not reported.